Results 141 to 150 of about 40,312 (250)
Impulse: The Premier Undergraduate Neuroscience Journal, 2017 Cigarette smoking damages just about every organ in the body and reduces overall health. Even with the prevalence of accessible nicotine replacement therapies and behavioral counseling, there remains a need for alternative therapies to improve the odds ...
Adrian Paszek
doaj
Unexpected aggressive behaviour: Interaction of bupropion and alcohol
, 2011 Percy Chandler, Andrew Herxheimer
openalex +2 more sources
Leading Causes of Death in Vietnam [PDF]
, 2017 Vietnam is currently facing a public health crisis. Rates of chronic and preventable diseases are climbing, in addition to mortality rates from these diseases.
Roth, Lindsey
core +1 more source
Bupropion SR for the treatment of smokeless tobacco use
, 2007 Lowell C. Dale +6 more
openalex +1 more source
Smoking Cessation Pharmacogenetics: Analysis of Varenicline and Bupropion in Placebo-Controlled Clinical Trials [PDF]
, 2011 David P. King +8 more
openalex +1 more source
Medicaid spending burden among beneficiaries with treatment-resistant depression. [PDF]
, 2019 AIM: To evaluate Medicaid spending and healthcare resource utilization (HRU) in treatment-resistant depression (TRD). MATERIALS & METHODS: TRD beneficiaries were identified from Medicaid claims databases (January 2010-March 2017) and matched 1:1 with ...
Greenberg, Paul E. +7 more
core +1 more source
Olanzapine Attenuates Cue-elicited Craving for Tobacco
, 2004 Rationale: Recent biological conceptualizations of craving and addiction have implicated mesolimbic dopamine activity as a central feature of the process of addiction. Imaging, and pharmacological studies have supported a role for dopaminergic structures
Hutchinson, Kent E +5 more
core
Preparation and <em>In-vitro</em> Evaluation of Gastroretentive Bupropion Hydrochloride Tablets
, 2012 Farnaz Fouladi, SA Mortazavi
openalex +2 more sources
Naltrexone/bupropion for obesity: An investigational combination pharmacotherapy for weight loss
, 2014 Sonja K. Billes +2 more
openalex +2 more sources
A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II) [PDF]
, 2013 Caroline M. Apovian +7 more
openalex +1 more source